Growth Metrics

Evaxion A (EVAX) Short term Debt (2021 - 2025)

Evaxion A posted quarterly Short term Debt of $190000.0 for Q4 2025, up 19.5% year-on-year from $159000.0 in Q4 2024, and up 3.26% on a QoQ basis from $184000.0 in Q2 2025.

Evaxion A (EVAX) has 5 years of Short term Debt data on file, last reported at $190000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Short term Debt rose 19.5% year-over-year to $190000.0; the trailing twelve-month figure through Dec 2025 stood at $190000.0 (up 19.5% YoY), and the FY2025 full-year result was $190000.0, up 19.5% from the prior year.
  • Short term Debt for Q4 2025 stood at $190000.0, up from $184000.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $190000.0 in Q4 2025 and bottomed at $119000.0 in Q2 2022.
  • The 5-year median for Short term Debt is $158000.0 (2024), against an average of $151545.5.
  • The widest annual swing landed in 2023, when Short term Debt rose 27.73%; it then changed 0.0% in 2024.
  • A 5-year view of Short term Debt shows it stood at $126000.0 in 2021, then gained by 7.94% to $136000.0 in 2022, then advanced by 16.91% to $159000.0 in 2023, then changed by 0.0% to $159000.0 in 2024, then gained by 19.5% to $190000.0 in 2025.
  • The last three Short term Debt figures came in at $190000.0 (Q4 2025), $184000.0 (Q2 2025), and $159000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 190,000.00
Jun 30, 2025 184,000.00
Dec 31, 2024 159,000.00
Jun 30, 2024 158,000.00
Dec 31, 2023 159,000.00
Jun 30, 2023 152,000.00
Dec 31, 2022 136,000.00
Jun 30, 2022 119,000.00
Mar 31, 2022 125,000.00
Dec 31, 2021 126,000.00
Sep 30, 2021 159,000.00